Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children
- PMID: 30134292
- DOI: 10.1097/QAD.0000000000001985
Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children
Abstract
Objectives: To assess and compare neurodevelopmental disorders in HIV-exposed uninfected (HEU) and HIV-unexposed uninfected (HUU) children in British Columbia, Canada. To determine associations between these outcomes and in-utero exposure to antiretroviral drugs.
Design: Retrospective controlled cohort study.
Methods: Data were collected on 446 HEU children and 1323 HUU children (matched ∼1 : 3 for age, sex, and geocode) born between 1990 and 2012. Multivariable logistic regressions determined odds ratios of neurodevelopmental disorder diagnoses.
Results: HEUs had three times higher odds of being born preterm (P < 0.0001), and a more than two-fold increase in odds for autism, disturbance of emotions, hyperkinetic syndrome, and developmental delay compared with matched HUUs (P < 0.02) in unadjusted analysis. This association was reduced [adjusted neurodevelopmental disorder odds ratio (AOR) = 1.67; 95% confidence interval: 1.12-2.48; P = 0.011] after adjusting for maternal substance use and/or smoking (children born after April 2000). Regardless of antiretroviral exposure type (i.e. none, treatment with one or multiple drug classes), HEUs had higher odds of any neurodevelopmental disorders compared with matched HUUs; however, there was no evidence suggesting any specific classes of antiretroviral drugs or exposure durations increased their likelihood of neurodevelopmental disorders.
Conclusion: The results suggest no adverse associations between antiretroviral drugs and neurodevelopmental disorders within antiretroviral-exposed HEU children in our cohort. Prevalence of neurodevelopmental disorders is higher in HEUs; however, maternal substance use plays a role, as could other environmental factors not captured. These findings highlight a need for holistic support for pregnant women as well as careful developmental monitoring of HEUs past infancy, and access to early interventions, particularly among those born preterm and those exposed to addictive substances.
Similar articles
-
Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV.AIDS Care. 2014;26(11):1327-35. doi: 10.1080/09540121.2014.920949. Epub 2014 May 30. AIDS Care. 2014. PMID: 24878112 Free PMC article. Clinical Trial.
-
Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.J Infect Dis. 2018 Feb 14;217(5):710-720. doi: 10.1093/infdis/jix618. J Infect Dis. 2018. PMID: 29228317 Free PMC article.
-
Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study.Lancet Child Adolesc Health. 2019 Nov;3(11):803-813. doi: 10.1016/S2352-4642(19)30250-0. Epub 2019 Sep 9. Lancet Child Adolesc Health. 2019. PMID: 31515160 Free PMC article.
-
In utero antiretroviral exposure and sociodemographic characteristics on neurodevelopment of HIV-exposed uninfected children versus HIV-unexposed uninfected healthy children in Malawi.Int J Gynaecol Obstet. 2021 Jun;153(3):424-437. doi: 10.1002/ijgo.13511. Epub 2020 Dec 31. Int J Gynaecol Obstet. 2021. PMID: 33270235
-
Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers.Curr Opin HIV AIDS. 2016 Sep;11(5):465-476. doi: 10.1097/COH.0000000000000300. Curr Opin HIV AIDS. 2016. PMID: 27716731 Review.
Cited by
-
Developmental Disorder Probability Scores at 6-18 Years Old in Relation to In-Utero/Peripartum Antiretroviral Drug Exposure among Ugandan Children.Int J Environ Res Public Health. 2022 Mar 21;19(6):3725. doi: 10.3390/ijerph19063725. Int J Environ Res Public Health. 2022. PMID: 35329408 Free PMC article.
-
Altered White Matter Tracts in the Somatosensory, Salience, Motor, and Default Mode Networks in 7-Year-Old Children Living with Human Immunodeficiency Virus: A Tractographic Analysis.Brain Connect. 2022 May;12(4):302-319. doi: 10.1089/brain.2020.0948. Epub 2021 Aug 23. Brain Connect. 2022. PMID: 34107770
-
In utero and peripartum antiretroviral exposure as predictor of cognition in 6- to 10-year-old HIV-exposed Ugandan children - a prospective cohort study.HIV Med. 2021 Aug;22(7):592-604. doi: 10.1111/hiv.13094. Epub 2021 Apr 16. HIV Med. 2021. PMID: 33860626 Free PMC article.
-
In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice.PLoS One. 2020 Nov 19;15(11):e0242513. doi: 10.1371/journal.pone.0242513. eCollection 2020. PLoS One. 2020. PMID: 33211746 Free PMC article.
-
Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.J Infect Dis. 2021 Feb 24;223(4):621-631. doi: 10.1093/infdis/jiaa410. J Infect Dis. 2021. PMID: 32638023 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
